This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Controlled Substances Remove Inventory Control Related Topics
Omnicell Patient Care Packaging Compounding FDA More Related Topics >
article thumbnail

Illuminate 2021 – Common Medication Safety Hazards with Automated Dispensing Cabinets

Omnicell

JANUARY 10, 2023

Len Hom Director, Product Marketing, Omnicell While there are many benefits to using automated dispensing cabinets (ADCs), such as increased inventory control and efficiency in drug dispensing practices, limits on configuration and functionality combined with underutilization of safety procedures can pose serious risks.

Omnicell 52
Omnicell Inventory Control Controlled Substances Packaging 52
article thumbnail

Cannabis Advocates High On Recent Medical Marijuana Research Legislation

The FDA Law Blog

JANUARY 8, 2023

As a reminder, the Controlled Substances Act (“CSA”) and DEA regulations require that research with cannabis and other schedule I drugs can only be conducted with a protocol approved by DEA and FDA. Such other conduct which may threaten the public health and safety. 21 U.S.C. § Research Protocols. 21 C.F.R. §§ 1301.13(e),

Controlled Substances 64
Controlled Substances Inventory Control Compounding FDA 64
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024